News

Using new cold plasma technology which he developed in the Plasma Engineering Research Lab (PERL) at Texas A&M University-Corpus Christi, Dr. Magesh Thiyagarajan is stopping these killer bacteria before they find a host.

Infection prevention and control (IP&C), as a discipline grounded in implementation science, must simultaneously incorporate research, innovation and experience from academia, industry, and clinical practice to best serve the needs of the patient. As the Association for Professionals in Infection Control and Epidemiology (APIC) gathers for its 40th Annual Conference this month, it seems an opportune time to reflect on the interdependence of the main players in working toward the vision of healthcare without infection and the role that industry plays in advancing the work of our members.